Makoto Asada

4.3k total citations
49 papers, 2.8k citations indexed

About

Makoto Asada is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Makoto Asada has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Epidemiology. Recurrent topics in Makoto Asada's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Chemical Synthesis and Analysis (4 papers). Makoto Asada is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Chemical Synthesis and Analysis (4 papers). Makoto Asada collaborates with scholars based in Japan, United States and Switzerland. Makoto Asada's co-authors include Junji Matsui, Toshimitsu Uenaka, Yasuhiro Funahashi, Akihiko Tsuruoka, Kentaro Yoshimatsu, Toshiaki WAKABAYASHI, Tatsuo Watanabe, John T. Galambos, Yuji Yamamoto and Tatsuo Watanabe and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

In The Last Decade

Makoto Asada

46 papers receiving 2.7k citations

Peers

Makoto Asada

ONCOL

EPIDE

IMMUN

Naoyuki Kanzaki Japan

Shonen Yoshida Japan

Jacques Jolivet Canada

Rong‐Guang Shao China

Jörg Stürzebecher Germany

László Őrfi Hungary

Kazuhisa Taketa Japan

Peter Charlton United Kingdom

Andrew M. Stern United States

Akulapalli Sudhakar United States

Naoyuki Kanzaki Japan

Makoto Asada

1.2k ×0.9

646 ×1.1

ONCOL

570 ×1.5

137 ×0.4

EPIDE

634 ×1.9

IMMUN

Citations per year, relative to Makoto Asada Makoto Asada (= 1×) peers Naoyuki Kanzaki

Countries citing papers authored by Makoto Asada

Since Specialization

Citations

This map shows the geographic impact of Makoto Asada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Asada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Asada more than expected).

Fields of papers citing papers by Makoto Asada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Asada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Asada. The network helps show where Makoto Asada may publish in the future.

Co-authorship network of co-authors of Makoto Asada

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Asada. A scholar is included among the top collaborators of Makoto Asada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Asada. Makoto Asada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ozawa, Yoichi, Kazutomi Kusano, Takashi Owa, et al.. (2012). Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment. Cancer Chemotherapy and Pharmacology. 69(5). 1353–1362. 45 indexed citations

Nakamoto, Kazutaka, I. TSUKADA, Keigo Tanaka, et al.. (2010). Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives. Bioorganic & Medicinal Chemistry Letters. 20(15). 4624–4626. 37 indexed citations

Nakagawa, Takayuki, Osamu Tohyama, Atsumi Yamaguchi, et al.. (2009). E7050: A dual c‐Met and VEGFR‐2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models. Cancer Science. 101(1). 210–215. 97 indexed citations

Iwata, Masao, Toshimitsu Uenaka, Yoichi Ozawa, et al.. (2007). E7107: Antitumor activity on human SCLC and cervical cancer xenografts in relation to its potential predictive markers of response.. Cancer Research. 67. 5608–5608. 1 indexed citations

Matsui, Junji, Yuji Yamamoto, Yasuhiro Funahashi, et al.. (2007). E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition. International Journal of Cancer. 122(3). 664–671. 434 indexed citations

Yamamoto, Yuji, Tatsuo Watanabe, Akihiko Tsuruoka, Toshiaki WAKABAYASHI, & Makoto Asada. (2006). E7080, an oral multitargeted tyrosine kinase inhibitor, has direct anti-tumor efficacy via inhibition of KIT signaling in gastrointestinal stromal tumor (GIST). Cancer Research. 66. 952–952. 2 indexed citations

Asada, Makoto, et al.. (2005). Preparation and Root Growth-Inhibitory Activity of N-Substituted 2-(2-Chloroacetamido)-3-(furan-2-yl)propanamides. Chemical and Pharmaceutical Bulletin. 53(9). 1183–1189.

Niijima, Jun, Yoshihiko Kotake, Mitsuo Nagai, et al.. (2004). E7107, a new 7-urethane derivative of pladienolide D: Discovery of a novel antitumor agent. Cancer Research. 64. 691–691. 18 indexed citations

Mizui, Yoshiharu, Takashi Sakai, Masao Iwata, et al.. (2004). Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 III. In Vitro and In Vivo Antitumor Activities. The Journal of Antibiotics. 57(3). 188–196. 163 indexed citations

10.

Semba, Taro, Yasuhiro Funahashi, Yuji Yamamoto, et al.. (2004). An Angiogenesis Inhibitor E7820 Shows Broad-Spectrum Tumor Growth Inhibition in a Xenograft Model. Clinical Cancer Research. 10(4). 1430–1438. 62 indexed citations

11.

Matsui, Junji, Toshiaki WAKABAYASHI, Makoto Asada, Kentaro Yoshimatsu, & Masayuki Okada. (2004). Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells. Journal of Biological Chemistry. 279(18). 18600–18607. 169 indexed citations

12.

Yamamoto, Yuji, Tatsuo Watanabe, Kazuki Miyazaki, et al.. (2004). E7080, an oral multitargeted tyrosine kinase inhibitor, has direct anti-tumor efficacy via inhibition of KIT signaling in small cell lung cancer. Cancer Research. 64. 1070–1071. 1 indexed citations

13.

Asada, Makoto, et al.. (2004). Improved Preparation of Racemic 2-Amino-3-(heteroaryl)propanoic Acids and Related Compounds Containing a Furan or Thiophene Nucleus. Chemical and Pharmaceutical Bulletin. 52(9). 1137–1139. 5 indexed citations

14.

Owa, Takashi, et al.. (2004). 420 The combination of Indisulam (E7070) with cisplatin, oxaliplatin and 5-fluorouracil are synergistic in vitro and in vivo. European Journal of Cancer Supplements. 2(8). 126–126. 5 indexed citations

15.

Shimizu, Hajime, Takashi Seiki, Makoto Asada, Kentaro Yoshimatsu, & Noriyuki Koyama. (2003). α6β1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells. Oncogene. 22(6). 831–839. 14 indexed citations

16.

Shimizu, Hajime, Noriyuki Koyama, Makoto Asada, & Kentaro Yoshimatsu. (2002). Aberrant expression of integrin and erbB subunits in breast cancer cell lines. International Journal of Oncology. 21(5). 1073–9. 16 indexed citations

17.

Asada, Makoto, et al.. (1999). Inhibition by Alkylamines of NADPH Oxidase Through Blocking the Assembly of Enzyme Components. The Japanese Journal of Pharmacology. 80(3). 237–242. 2 indexed citations

18.

Asada, Makoto, Hiroyuki Nunoi, Ichiro Matsuda, et al.. (1993). Combination of Arachidonic Acid and Guanosine 5′-O-(3-Thiotriphosphate) Induces Translocation of rac p21s to Membrane and Activation of NADPH Oxidase in a Cell-Free System. Biochemical and Biophysical Research Communications. 195(1). 264–269. 29 indexed citations

19.

Yoshino, Hiroshi, Norihiro Ueda, Jun Niijima, et al.. (1992). Novel sulfonamides as potential, systemically active antitumor agents. Journal of Medicinal Chemistry. 35(13). 2496–2497. 208 indexed citations

20.

Hiraoka, Kunihiko, Kozo Kaibuchi, Satoshi Ando, et al.. (1992). Both stimulatory and inhibitory exchange proteins, smg GDS and rho GDI, are active on multiple small GTP-binding proteins. Biochemical and Biophysical Research Communications. 182(2). 921–930. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact